AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Bupivacaine Hydrochloride in South Africa

8 products registered with SAHPRA 6 active

Brand / ProductReg. No.HolderStatusExpires
REGIBLOC SPINAL 0,75% m/v INJECTIONZ/4/95BODENE (PTY) LTD TRADING AS INTRAMEDsuspended22 Jun 2025
BUPICAN45/4/0127Biotech Laboratories (Pty) Ltdsuspended10 Mar 2023
MACAINE VIAFLEX 0,1 %A40/4/0182Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900
BUPIVACAINE HCL 0,5% (10ml) FRESENIUSW/4/335Fresenius Kabi Manufacturing SA (Pty) Ltdactive1 Jan 1900
PHARMA-Q BUPIVACAINE INJECTION 50 mg/10 ml31/4/0007Pharma-Q Holdings (Pty) Ltdactive1 Jan 1900
BUPIVACAINE HCL 0,5% SPINAL (4ml) FRESENIUS29/4/0558Fresenius Kabi Manufacturing SA (Pty) Ltdactive1 Jan 1900
PHARMA-Q BUPIVACAINE SPINAL WITH DEXTROSE INJECTION (20 mg/4ml)31/4/0006Pharma-Q Holdings (Pty) Ltdactive1 Jan 1900
MACAINE HCL 0,5% SPINAL INJECTION WITH DEXTROSEU/4/91Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900

Bupivacaine HydrochlorideSAHPRA Registration Details

SAHPRA (South Africa) has 8 registered products containing Bupivacaine Hydrochloride, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Bupivacaine Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.